Table 2.
Median percentage time (and IQR) spent within various glucose ranges, at baseline (weeks −2 to 0) and endpoint (4–8 weeks), and median change (and 95% confidence interval) in percentage time for continuous and flash glucose monitoring
| Percentage time within defined glucose range | Continuous glucose monitoring (n = 19) Median (IQR) | Flash glucose monitoring (n = 20) Median (IQR) | Median change from baseline (95% CI) | ||||
|---|---|---|---|---|---|---|---|
| Baseline (−2 to 0 weeks) | Endpoint (4 to 8 weeks) | Baseline (−2 to 0 weeks) | Endpoint (4 to 8 weeks) | Continuous glucose monitoring | Flash glucose monitoring | P‐value | |
| < 2.8 mmol/l | 2.3 (0.6–10.7) | 0.9 (0.2–1.8) | 4.1 (2.5–5.9) | 3.8 (3.0–6.4) | −1.2 (−4.3 to −0.5) | 1.3 (−1.0 to 2.4) | 0.003 |
| < 3.3 mmol/l | 4.5 (1.9–14.1) | 2.4 (1.0–5.1) | 6.7 (4.8–9.5) | 6.8 (4.8–11.7) | −3.0 (−5.0 to −0.3) | 1.3 (−1.4 to 3.6) | 0.006 |
| < 3.5 mmol/l | 5.5 (3.1–15.7) | 3.5 (1.8–6.3) | 8.0 (5.7–10.7) | 8.2 (6.0–13.2) | −2.8 (−4.7 to −0.3) | 2.0 (−1.0 to 4.7) | 0.004 |
| < 3.9 mmol/l | 8.8 (5.7–19.5) | 6.2 (3.1–10.2) | 11.9 (8.8–13.7) | 11.0 (8.2–17.0) | −2.7 (−6.1 to −0.1) | 0.6 (−2.1 to 5.4) | 0.01 |
| > 7.8 mmol/l | 48.8 (40.8–70.0) | 49.0 (36.6–58.1) | 50.3 (43.9–58.6) | 47.1 (37.4–53.5) | −3.4 (−10.5 to 1.4) | −5.9 (−15.0 to 5.6) | 0.57 |
| > 10 mmol/l | 33.3 (25.2–49.9) | 26.7 (16.9–37.4) | 35.0 (21.9–38.7) | 28.0 (18.0–32.1) | −8.6 (−13.0 to −1.1) | −7.0 (−16.9 to 1.7) | 0.71 |
| > 15 mmol/l | 10.0 (1.6–20.4) | 4.2 (1.2–9.7) | 5.9 (2.7–9.2) | 2.6 (1.2–5.1) | −4.9 (−8.6 to −0.7) | −3.1 (−5.3 to −0.4) | 0.48 |
| 3.9–7.8 mmol/l | 31.7 (24.1–43.8) | 43.7 (34.7–52.3) | 34.8 (30.2–44.1) | 40.4 (34.7–45.3) | 10.6 (3.3 to 14.4) | 5.9 (−2.4 to 9.0) | 0.15 |
| 3.9–10 mmol/l | 50.2 (40.8–66.5) | 65.9 (53.5–74.8) | 54.1 (47.5–64.5) | 60.0 (54.5–67.8) | 12.7 (7.2 to 15.8) | 5.3 (1.1 to 11.7) | 0.05 |